Meso and Asbestos Research | Science Advisory Board | Edward Levine, MD

Funding mesothelioma and asbestos research and providing education and support are the two main goals of the Meso Foundation. The guidance and expertise provided by our Science Advisory Board helps up achieve this. Made up of the best mesothelioma researchers and doctors in their fields, the Board strives to aid mesothelioma research and continues to make strides toward finding a cure.

Among those on our board of mesothelioma and asbestos research experts is Dr. Edward Levine.

Meet Edward Levine, MD

Asbestos and Mesothelioma Research Experts: Edward Levine, MD

Edward Levine is Professor of Surgery and Chief of the Surgical Oncology Service. He is 1 of 6 faculty members of the Surgical Oncology Service. He received his medical degree at the Chicago Medical School in 1985. His residency in general surgery was as the Michael Reese Hospital in Chicago. He subsequently completed a surgical oncology fellowship at the University of Illinois 1990-1992. After his surgical training, Dr. Levine joined the faculty at Louisiana State University in New Orleans where he was promoted to Associate Professor in 1997. He joined the Wake Forest University faculty in August 1998 and was promoted to Professor in 2002. He has published over 175 scientific articles and book chapters.

Dr. Levine's clinical interests are related to general surgical oncology with a focus on mesothelioma, melanoma, sarcoma, breast and gastrointestinal malignancy. He is director of the Surgical Oncology Clinics, the multimodality breast clinic and the surgical oncology Conference (“Tumor Board”) for the Comprehensive Cancer Center. Dr. Levine is a member of the Internal Advisory Board of the Wake Forest University Comprehensive Cancer Center.

Dr. Levine is the principal investigator for approximately 25 current clinical/translational protocols and is committed to clinical/translational research. These involve the National Surgical Breast and Bowel Project (NSABP) and the American College of Surgeons Oncology Group (ACOSOG) for which he is the institutional principal investigator. He is also the leader of the Wake Forest University program of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis, which is the second largest such program in the western hemisphere. He is also the recipient of grants from the National Cancer Institute, Industry, and Cancer Center funding translational research involving the genomic analysis of solid tumors.


Believe in a Cure!

Contact us here for immediate expert help and a free copy of the book "100 Questions & Answers About Mesothelioma."

(877) END-MESO
(877) 363-6376